Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.33−0.19 (-12.76%)
Close on Nov 18, 2026Market cap $21.75MP/E –Yield –
Cellyan Biotechnology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was -$751.60K, down 232.0% from the year before.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$751.60K | -232.0% |
| FY2025 | Mar 31, 2025 | $569.21K | – |
| FY2024 | Mar 31, 2024 | -$394.33K | -122.8% |
| FY2023 | Mar 31, 2023 | $1.73M | – |
See a number that looks wrong?